Frequent EGFR involvement in NSCLC include a point mutation in exon 21 (~40% sufferers) besides exon 19 deletion (E746–A750), resulting in codon 858 substitution (L858R). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.